Suchergebnisse - "Tabernero, J"

PubPharm (440)

11

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors

enthalten in: ESMO open | 2022

von Le Tourneau, C. | Becker, H. | Claus, R. | +10

12

MODUL cohort 2 : an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer

enthalten in: ESMO open | 2022

von Tabernero, J. | Grothey, A. | Arnold, D. | +8

13

Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors

enthalten in: ESMO open | 2022

von Borazanci, E. | Schram, A. | Garralda, E. | +20

14

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer : patient-reported outcomes from BEACON CRC

enthalten in: ESMO open | 2022

von Kopetz, S. | Grothey, A. | Van Cutsem, E. | +14

15

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer

enthalten in: ESMO open | 2022

von Mirallas, O. | López-Valbuena, D. | García-Illescas, D. | +4

16

Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors : first-in-human dose-escalation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Gazzah, A. | Bedard, P. | Hierro, C. | +9

17

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers

enthalten in: ESMO open | 2022

von Tabernero, J. | Andre, F. | Blay, J. | +7

18

The impact of COVID-19 on cancer care and oncology clinical research : an experts' perspective

enthalten in: ESMO open | 2022

von Sessa, C. | Cortes, J. | Conte, P. | +12

CommentIn: ESMO Open. 2022 Aug;7(4):100537. - PMID 35868220

19

Future care for long-term cancer survivors : towards a new model

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2022

von Provencio, M. | Romero, N. | Tabernero, J. | +18

20

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies

enthalten in: ESMO open | 2021

von Berghoff, A. | Sessa, C. | Yang, J. | +18